Arialys - About the company
Arialys is a seed company based in La Jolla (United States), founded in 2021. It operates as a Company focused on developing precision medicines for autoimmune neuropsychiatric diseases. Arialys has raised $72.8M in funding from investors like Alexandria, Johnson & Johnson Innovation – JJDC and Catalys Pacific. The company has 968 active competitors, including 40 funded and 62 that have exited. Its top competitors include companies like The Fertility Partners, IBX and Cascador Health.
Company Details
It is a private biotech company focused on developing new precision medicines for autoimmune neuropsychiatric diseases. They are exploring scientific breakthroughs in this field and aim to provide therapeutic solutions for those affected by these conditions.
- Website
- arialysrx.com
- Email ID
- *****@arialysrx.com
Key Metrics
Founded Year
2021
Location
La Jolla, United States
Stage
Seed
Total Funding
$72.8M in 2 rounds
Latest Funding Round
Investors
Ranked
6th among 968 active competitors
Employee Count
14 as on Sep 30, 2026
Similar Companies
Sign up to download Arialys' company profile
Arialys's funding and investors
Arialys has raised a total funding of $72.8M over 2 rounds. Its first funding round was on Sep 12, 2023. Arialys has 4 institutional investors.
Here is the list of recent funding rounds of Arialys:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 13, 2025 | 5706160 | Seed | 1634870 | 3623704 | 4814972 | 6736952 |
Sep 12, 2023 | 6380576 | Seed | 1770382 | 6786817 | 2865786 |
Access funding benchmarks and valuations. Sign up today!View details of Arialys's funding rounds and investors
Arialys' founders and board of directors
Founder? Claim ProfileArialys' employee count trend
Arialys has 14 employees as of Sep 26. Here is Arialys's employee count trend over the years:
Uncover Arialys' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Arialys's Competitors and alternates
Top competitors of Arialys include The Fertility Partners, IBX and Cascador Health. Here is the list of Top 10 competitors of Arialys, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  The Fertility Partners 2019, Toronto (Canada), Series C | Provider of business consulting services for the fertility practices | $67.1M | 63/100 | |
2nd |  IBX 1938, Philadelphia (United States), Unfunded | Provider of health insurance and information services | - | - | 57/100 |
3rd |  Cascador Health 2021, Temse (Belgium), Series A | Provider of patient data management services for healthcare providers | $3.74M | 50/100 | |
4th | Teitur Trophics 2020, Aarhus (Denmark), Series A | Provider of neurodegenerative therapeutics development services | $30M | 49/100 | |
5th | George Institute 1999, Newtown (Australia), Series C | Medical research institute | $35M | 49/100 | |
6th |  Arialys 2021, La Jolla (United States), Seed | Company focused on developing precision medicines for autoimmune neuropsychiatric diseases | $72.8M | 47/100 | |
7th |  NHS Scotland 1948, Edinburgh (United Kingdom), Unfunded | Network providing health information, resources, and news for professionals. | - | - | 46/100 |
8th |  Veracity-Health Funding Raised | Provider of a clinical decision-support search engine for medical professionals | - | 45/100 | |
9th | Provider of eye health education and technological solutions | - | 44/100 | ||
10th |  Interior Health 2001, Kelowna (Canada), Unfunded | Provider of healthcare information | - | - | 43/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Arialys's competitors? Click here to see the top ones
Arialys's Investments and acquisitions
Arialys has made no investments or acquisitions yet.
Reports related to Arialys
Here is the latest report on Arialys's geography:
News related to Arialys
Filter this listMedia has covered Arialys for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
•
Arialys Therapeutics Announces First ANRE Patient Treated with ART5803 and FDA Clearance of IND for Phase 2 StudyBusiness Wire•Jun 15, 2026•Arialys
•
Arialys Therapeutics Receives FDA Rare Pediatric Disease Designation for ART5803Business Wire•Sep 25, 2025•Arialys
•
Arialys Therapeutics: Preclinical Data for ART5803 in Nature CommunicationsBusiness Wire•Jun 17, 2025•Arialys
•
Arialys Therapeutics Publishes Preclinical Data Supporting ART5803 as a Therapeutic for Neuropsychiatric DiseaseBusiness Wire•Jun 17, 2025•Arialys
•
•
•
Arialys Therapeutics Appoints Sankalp Gokhale, M.D., Chief Medical OfficerArialys•Oct 22, 2024•Arialys
•
Arialys Therapeutics Appoints Sankalp Gokhale, M.D., Chief Medical OfficerBusiness Wire•Oct 22, 2024•Arialys, Dianthus Therapeutics
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Arialys
Explore our recently published companies
- Techvedi Shopping Solution pvt Ltd - Jaipur based, 2019 founded, Unfunded company
- Testmandi - Cuddalore based, 2021 founded, Unfunded company
- getmetutor.com - Ujjain based, Unfunded company
- Ri Lang Tech Solutions - India based, 2017 founded, Unfunded company
- Intelli Schools - Dehradun based, 2017 founded, Unfunded company
- KoSolve - Gurugram based, 2018 founded, Deadpooled company
